Definium Therapeutics, Inc. lost $2.06 per diluted share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to a loss of $3.11 per diluted share. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Definium Therapeutics, Inc. has filed alongside them.
FY2025 annual
EPS (Diluted)-$2.06
YoYn/m
Ticker history: MNMD became
DFTX
(Definium Therapeutics, Inc.) on .
Earlier news and filings retain their original names and dates.
View MNMD history.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Definium Therapeutics, Inc. lost $2.06 per diluted share in fiscal year 2025.
Definium Therapeutics, Inc. (DFTX) reported a loss of $1.54 per diluted share in fiscal year 2024 and a loss of $2.06 per diluted share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Definium Therapeutics, Inc. (DFTX) reported a loss of $3.11 per diluted share over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.
Across the 6 fiscal years this page covers, Definium Therapeutics, Inc. (DFTX) diluted earnings per share went from -$0.13 in fiscal year 2020 to -$2.06 in fiscal year 2025.
Definium Therapeutics, Inc. (DFTX) reported -$0.46 in diluted earnings per share in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Definium Therapeutics, Inc. (DFTX) reported on that line in every period on record.
